| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/24/2003 | CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor |
| 09/24/2003 | CN1444483A Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides |
| 09/24/2003 | CN1444479A Medicaments containing cilansetron for treating non-obstipated male IBS patients |
| 09/24/2003 | CN1444477A Thrombopoietin mimetics |
| 09/24/2003 | CN1444476A Method for reducing exacerbations associated with COPD |
| 09/24/2003 | CN1444474A Nonoral preparation having three-layer structure |
| 09/24/2003 | CN1443575A Medicine for curing metabolic syndrome |
| 09/24/2003 | CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate |
| 09/23/2003 | US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units |
| 09/23/2003 | US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/23/2003 | US6624193 Preventive and therapeutic agents for eye diseases |
| 09/23/2003 | US6624185 Drugs at least one lipid- or triglyceride-lowering active compound; and carriers for lipid metabolism |
| 09/23/2003 | US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders |
| 09/23/2003 | US6624181 Synergistic combination |
| 09/23/2003 | US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 09/23/2003 | US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and |
| 09/23/2003 | US6624154 Compositions and methods for treatment of hyperproliferative diseases |
| 09/23/2003 | US6624148 Synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of |
| 09/23/2003 | US6624142 Trimethyl lock based tetrapartate prodrugs |
| 09/23/2003 | US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same |
| 09/23/2003 | US6623758 Controlled release synergistic treatment of bacterial infections |
| 09/23/2003 | US6623757 Mixture of antibiotics; variations of releasing profiles |
| 09/23/2003 | US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis |
| 09/23/2003 | CA2281570C Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 09/23/2003 | CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 09/23/2003 | CA2115442C Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist |
| 09/23/2003 | CA2066807C Contraception in female primates without affecting the menstrual cycle |
| 09/23/2003 | CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia |
| 09/21/2003 | CA2422623A1 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (cns) and/or in other parenchymal organs |
| 09/19/2003 | WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression |
| 09/19/2003 | CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression |
| 09/18/2003 | WO2003076631A2 Genetic products differentially expressed in tumors and use thereof |
| 09/18/2003 | WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene |
| 09/18/2003 | WO2003076603A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions |
| 09/18/2003 | WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 09/18/2003 | WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/18/2003 | WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer |
| 09/18/2003 | WO2003076579A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
| 09/18/2003 | WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides |
| 09/18/2003 | WO2003076445A2 Microtubule stabilizing compounds |
| 09/18/2003 | WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076400A1 New inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076393A1 Salts of nateglinide |
| 09/18/2003 | WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer |
| 09/18/2003 | WO2003075958A1 Remedies for sex hormone-dependent disease |
| 09/18/2003 | WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| 09/18/2003 | WO2003075948A1 NOVEL FUNCTION OF Wnt AND APPLICATION THEREOF TO TREATMENT OF DISEASES |
| 09/18/2003 | WO2003075946A2 Treatment of type i diabetes mellitus using growth hormone antagonist |
| 09/18/2003 | WO2003075943A2 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol |
| 09/18/2003 | WO2003075933A1 Composition for reducing blood glucose and cholesterol |
| 09/18/2003 | WO2003075930A1 Synergistic enhancement of cognitive ability |
| 09/18/2003 | WO2003075929A1 Inhibitors of histone deacetylase |
| 09/18/2003 | WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders |
| 09/18/2003 | WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 09/18/2003 | WO2003075920A1 Eye drops containing tetrazole derivative |
| 09/18/2003 | WO2003075917A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 09/18/2003 | WO2003075914A1 Citalopram for the treatment of elevated blood pressure |
| 09/18/2003 | WO2003075899A2 Combinations comprising epothilone derivatives and alkylating agents |
| 09/18/2003 | WO2003075893A1 Controlled release dosage forms |
| 09/18/2003 | WO2003075890A1 Methods for entrapment of bioactive agent in a liposome or lipid complex |
| 09/18/2003 | WO2003075889A1 An inhalation system for prevention and treatment of intracellular infections |
| 09/18/2003 | WO2003075887A1 Sustained release drug formulations containing a carrier peptide |
| 09/18/2003 | WO2003075884A1 Effervescent compositions comprising bisphosphonates and methods related thereto |
| 09/18/2003 | WO2003075852A2 Antibiotic composition |
| 09/18/2003 | WO2003075850A2 Methods for alzheimer's disease treatment and cognitive enhancement |
| 09/18/2003 | WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 09/18/2003 | WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 09/18/2003 | WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | WO2003075840A2 Human antibodies specific to kdr and uses thereof |
| 09/18/2003 | WO2003075836A2 Cathepsin cysteine protease inhibitors |
| 09/18/2003 | WO2003075833A2 Screening method for orthopoxvirus antivirals |
| 09/18/2003 | WO2003075832A2 Methods and composition based on discovery of metabolism of nitroclycerin |
| 09/18/2003 | WO2003075812A1 Controlled delivery patch of active ingredient |
| 09/18/2003 | WO2003075790A2 Gas-plasma treatment of implants |
| 09/18/2003 | WO2003075746A2 Methods for aneurysm repair |
| 09/18/2003 | WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 09/18/2003 | WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/18/2003 | WO2003059296A3 Compositions comprising collagen and metalloprotease inhibitors |
| 09/18/2003 | WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/18/2003 | WO2003054159A3 Modulating insulin receptor signaling through targeting facl |
| 09/18/2003 | WO2003047521A3 Composition and method for treatment of otitis media |
| 09/18/2003 | WO2003037310A3 Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents |
| 09/18/2003 | WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 09/18/2003 | WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/18/2003 | WO2003032928A3 Therapeutic composition and use |
| 09/18/2003 | WO2003031584A3 Axon repair |
| 09/18/2003 | WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 09/18/2003 | WO2003024489A3 Combination of a nsaid and a pde-4 inhibitor |
| 09/18/2003 | WO2003024442A3 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease |
| 09/18/2003 | WO2003012139A3 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 09/18/2003 | WO2003012060A9 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
| 09/18/2003 | WO2003011274A3 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 09/18/2003 | WO2002102388A3 Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism |
| 09/18/2003 | WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |